Medicaid Fee-for-Service

Medicaid Fee-for-Service

Help for your patients in need

Medicaid Fee-for-Service is a state-specific program. Coverage may depend on the indication as well as other factors. As this information varies by state, it is important to contact the state agency directly or consult its Web site to obtain product-specific coverage and other information.

Disclaimer: Janssen Biotech, Inc., the maker of TREMFYA®, does not endorse and is not responsible for the content on any of the Web sites listed below. Clicking on any of the links below will take you to a Web site to which this privacy policy does not apply. We encourage you to read the privacy policy of every Web site you visit.

Blank Entry: Not found in the public domain
Brand: A patented drug listed in PDL or supporting documents
Covered: Drug is listed in PDL or supporting documents
Preferred: Refers to the coverage level of a drug

State Preferred Drug List (PDL)* Status Prior Authorization Required
Alabama    
Alaska    
Arizona    
Arkansas See payer for details Yes
California    
Colorado    
Connecticut    
Delaware    
District of Columbia    
Florida    
Georgia    
Hawaii    
Idaho See payer for details Yes
Illinois    
Indiana    
Iowa    
Kansas    
Kentucky    
Louisiana    
Maine    
Maryland See payer for details Yes
Massachusetts    
Michigan    
Minnesota    
Mississippi See payer for details Yes
Missouri Covered  
Montana See payer for details Yes
Nebraska See payer for details Yes
Nevada    
New Hampshire    
New Jersey Covered  
New Mexico    
New York See payer for details Yes
North Carolina    
North Dakota See payer for details Yes
Ohio Covered Yes
Oklahoma Covered Yes
Oregon    
Pennsylvania    
Rhode Island    
South Carolina Covered  
South Dakota    
Tennessee    
Texas    
Utah Brand Yes
Vermont    
Virginia    
Washington See payer for details Yes
West Virginia    
Wisconsin See payer for details Yes
Wyoming    

* The title for each state's Medicaid Fee-for-Service drug list may vary (eg, Prescription Drug List, Contract Drug List).

R2

Indication

TREMFYA® is indicated for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

TREMFYA® is administered as a 100 mg subcutaneous injection once every 8 weeks, after starter doses at weeks 0 and 4. TREMFYA® is intended for use under the guidance and supervision of a physician. Patients may self-inject with TREMFYA® after physician approval and proper training.

Important Safety Information For TREMFYA®

Important Safety Information

Infections
TREMFYA® may increase the risk of infection. Treatment with TREMFYA® should not be initiated in patients with a clinically important active infection until the infection resolves or is adequately treated.

Consider the risks and benefits of treatment prior to prescribing TREMFYA® in patients with a chronic infection or a history of recurrent infection. Instruct patients receiving TREMFYA® to seek medical help if signs or symptoms of clinically important chronic or acute infection occur. If a patient develops a clinically important or serious infection, or is not responding to standard therapy, closely monitor and discontinue TREMFYA® until the infection resolves.

Pre-Treatment Evaluation for Tuberculosis (TB)
Evaluate patients for TB infection prior to initiating treatment with TREMFYA®. Initiate treatment of latent TB prior to administering TREMFYA®. Monitor patients for signs and symptoms of active TB during and after TREMFYA® treatment. Do not administer TREMFYA® to patients with active TB infection.

Immunizations
Prior to initiating TREMFYA®, consider completion of all age-appropriate immunizations according to current immunization guidelines. Avoid use of live vaccines in patients treated with TREMFYA®.

Adverse Reactions
Most common (≥1%) adverse reactions associated with TREMFYA® include upper respiratory infections, headache, injection site reactions, arthralgia, diarrhea, gastroenteritis, tinea infections, and herpes simplex infections.

Please read the full Prescribing Information and Medication Guide for TREMFYA®. Provide the Medication Guide to your patients and encourage discussion.

067010-170208